Magnis Energy Technologies (ASX:MNS) has provided an update on the operations of the Imperium3 New York Lithium-ion Battery Plant in New York, of which Magnis has a 61% interest.
The company says commercial cell production at the plant commenced in August of 2022, and involved internal qualifications.
Ten cells are provided for the certification process and all cells are required to pass all tests, and once the certification is received, Sukh Energy, an existing customer, has placed orders for delivery in 2023.
Magnis also has plans to set up an Active Anode Materials Project in the US.